Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations) read with part A of Schedule Ill of the Listing Regulations, Themis Medicare has informed that the management of the Company had a one-on-one conference call with Analysts/ Investors on Monday, 27th September, 2021; as details enclosed. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the
website of the company viz. www.themismedicare.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1806.45 |
| Dr. Reddys Lab | 1279.25 |
| Cipla | 1381.50 |
| Zydus Lifesciences | 1087.75 |
| Lupin | 2273.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: